Displaying 1 - 10 of 590
Living and thriving through a blood cancer experience
Updated:
LLSC is the largest voluntary health agency dedicated to funding blood cancer research, advocating for equitable access to treatment, and offering support
Connect with us
Updated:
If you have a lot of questions right now or you cannot find what you’re looking for, you’ve come to the right place. You can talk to us directly and receive personalized assistance in finding answers to your questions or ways to address your concerns. People who call us know…
Image
Myelofibrosis (MF) therapies: From palliation to disease modification - myeloproliferative neoplasms (MPN) conference 2025
Updated:
Dr. Vikas Gupta, Hematologist at the Princess Margaret Cancer Centre in Toronto, reviewed Myelofibrosis (MF) and the evolution in diagnosis, treatment options and aspects of follow-up care in this 1-hour webcast as part of MPN Conference 2025.
Myeloproliferative neoplasms
Image
Preparing for Treatment with Shae-Lynn
Updated:
After being diagnosed with leukemia at 21 years old, Shae-Lynn Way shares her experience with shifting her mindset while preparing for a second stem cell transplant after her leukemia returned.
Leukemia, Treatment and side effects
Polycythemia Vera (PV)
Updated:
Learn more about polycythemia vera (PV) and the resources we have available.
Myeloproliferative neoplasms
Myeloproliferative neoplasms
Updated:
Learn more about myeloproliferative neoplasms and the resources we have available.
Myeloproliferative neoplasms
Image
Understanding polycythemia vera (PV): Diagnosis, treatments and follow-up care - myeloproliferative neoplasms (MPN) conference 2025
Updated:
In this 1-hour live webcast, Dr. Sonia Cerquozzi, hematologist at the Tom Baker Cancer Center and Peter Lougheed Centre in Calgary, reviews PV, a type of MPN - its diagnosis, treatment options and aspects of follow-up care.
Myeloproliferative neoplasms
How we decide which projects to fund
Updated:
Learn more about our scientific review panels and medical and scientific advisory committee.
Essential thrombocythemia (ET)
Updated:
Learn more about essential thrombocythemia (ET) and the resources we have available.
Myeloproliferative neoplasms
Image
Understanding essential thrombocythemia (ET): Diagnosis, treatments and follow-up care: MPN conference 2025
Updated:
In this 1-hour webcast, Dr. Lynda Foltz, University of British Columbia, will review this type of myeloproliferative neoplasm (MPN): its diagnosis, treatment options, and aspects of follow-up care.) People with ET have too many platelets, a type of blood cell. Too many…
Myeloproliferative neoplasms